Document is current
Any future updates will be listed below
-
Authors
Huang, Siyu https://orcid.org/0000-0001-9488-2726
Chen, David C.
Hennes, David
Murphy, Declan G. https://orcid.org/0000-0002-7500-5899
Lawrentschuk, Nathan https://orcid.org/0000-0001-8553-5618
Perera, Marlon L. https://orcid.org/0000-0002-1138-6389
- License Information
-
More Information
Article History
First Online: 8 September 2025
Competing interests
: N.L. has received reimbursement for consulting and/or speaker duty from Ferring advisory board, Device Technologies, Getz Healthcare proctoring and Astellas. D.G.M. has received reimbursement for consulting and/or speaker duty from Janssen, Bayer, Astellas, Ipsen, AstraZeneca, Novartis, Cipla, Mundipharma and Device Technologies. M.L.P. is sponsored by the Australian–American Fulbright Commission administered through a 2021–2022 Fulbright Future Scholarship funded by The Kinghorn Foundation and has received reimbursement for consulting Novartis. The other authors declare no competing interests.
